Inhibition of Metabolism of the ‘Nonclassical’ Antifolate, Trimetrexate (2,4-Diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline) by Drugs Containing an Imidazole Moiety | Citedby Results | Pharmacology | Karger Publishers

Skip to Main Content

Skip Nav Destination

Inhibition of Metabolism of the ‘Nonclassical’ Antifolate, Trimetrexate (2,4-Diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline) by Drugs Containing an Imidazole Moiety

Pharmacology (1985) 30 (5): 266–272.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Biomarker-based assessment of the toxicity of the antifungal clotrimazol to the microcrustacean Daphnia magna

Madalena Vieira
Amadeu M.V.M. Soares
Bruno Nunes

Environmental Toxicology and Pharmacology (2019) 71: 103210.

Effect of trimethoprim, paracetamol and cimetidine on trimetrexate metabolism by rat perfused isolated livers

Lorraine K Webster
William P Tong
John J McCormack

Journal of Pharmacy and Pharmacology (2011) 39 (11): 942.

A guide to clinically relevant drug interactions in oncology

Masha S H Lam
Robert J Ignoffo

Journal of Oncology Pharmacy Practice (2003) 9 (2-3): 45.

Involvement of testosterone in the induction of hepatic microsomal cytochrome P-450 2B1/2 (P-450 2B1/2) by 1-benzylimadazole in male and female rats: sex-differentiated induction of P-450 2B1/2 species

Yasuna Kobayashi
Takemi Yoshida
Eiichi Kotani
Takaaki Aoyagi
Yukio Kuroiwa
Seisho Tobinaga

Biochimica et Biophysica Acta (BBA) - General Subjects (1994) 1200 (1): 11.

Effect of Chronically Administered Ketoconazole on the Elimination of Theophylline in Man

James J. Heusner
George E. Dukes
Douglas E. Rollins
Keith G. Tolman
Raymond E. Galinsky

Drug Intelligence & Clinical Pharmacy (1987) 21 (6): 514.

High magnitude hepatic cytochrome P-450 induction by an N-substituted imidazole antimycotic, clotrimazole

Joseph K. Ritter
Michael R. Franklin

Biochemical Pharmacology (1987) 36 (17): 2783.

Biological and biochemical properties of new anticancer folate antagonists

David W. Fry
Robert C. Jackson

Cancer and Metastasis Review (1987) 5 (3): 251.